Identification of immune dominant cytomegalovirus epitopes using quantitative real-time polymerase chain reactions to measure interferon-γ production by peptide-stimulated peripheral blood mononuclear cells

Journal of Immunotherapy

Volumn 25, Issue 4, 2002, Pages 342-351

  Provenzano, Maurizio ^a   Mocellin, Simone ^a   Bettinotti, Maria ^a   Preuss, Jeanne ^a   Monsurrò, Vladia ^a   Marincola, Francesco M ^a   Stroncek, David ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cytokines; Cytomegalovirus; Cytotoxic T lymphocytes; Immune therapy; Major histocompatibility complex; Transplantation

Indexed keywords

EPITOPE; GAMMA INTERFERON; GLUTAMYLTYROSYLASPARTYLPROLYLVALYLALANYLALANYLLEUCYLPHENYLALANINAMIDE; GLUTAMYLTYROSYLASPARTYLPROLYLVALYLALANYLALANYLLEUCYLPHENYLALANYLPHENYLALANI NAMIDE; GLUTAMYLTYROSYLVALYLLYSYLVALYLLEUCYLGLUTAMINYLSERYLPHENYLALANINAMIDE; IMMUNOSTIMULATING AGENT; ISOLEUCYLTYROSYLVALYLTYROSYLALANYLLEUCYLPROLYLLEUCYLLYSYLMETHIONINAMIDE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VALYLTYROSYLALANYLLEUCYLPROLYLLEUCYLLYSYLMETHIONYLLEUCINAMIDE; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; HLA A ANTIGEN; HLA A24 ANTIGEN; MATRIX PROTEIN; MESSENGER RNA; PEPTIDE; PHOSPHOPROTEIN; VIRUS ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ALGORITHM; ALLOGENEIC RESTRICTION; ALLOTRANSPLANTATION; AMINO ACID SEQUENCE; ARTICLE; COMPUTER PREDICTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IMMUNOSTIMULATION; IMMUNOTHERAPY; INFECTION PREVENTION; INTERFERON PRODUCTION; MONONUCLEAR CELL; MORBIDITY; NONHUMAN; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; QUANTITATIVE DIAGNOSIS; RNA ANALYSIS; SERODIAGNOSIS; STEM CELL TRANSPLANTATION; VIRUS INFECTION; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; GENETICS; IMMUNOLOGY; KINETICS; METHODOLOGY; SYNTHESIS; VIROLOGY;

ANTIGENS, VIRAL; CELLS, CULTURED; CYTOMEGALOVIRUS; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HLA-A ANTIGENS; HUMAN; IMMUNODOMINANT EPITOPES; INTERFERON TYPE II; KINETICS; LEUKOCYTES, MONONUCLEAR; PEPTIDES; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; VIRAL MATRIX PROTEINS; HUMANS;

EID: 0035990387     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200207000-00006     Document Type: Article

References (30)

1. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation
2. Neutralizing antibody response against human cytomegalovirus in allogeneic bone marrow-transplant recipients
3. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones
4. Principles for adoptive T cell therapy of human viral diseases
5. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
6. Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones
7. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes
8. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers
9. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection
10. The human cytotoxic T-lymphocyte (CTL) response to Cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T-cell receptor usage of pp65-specific CTL
11. Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus
12. Three T-cell epitopes within the C-terminal 265 amino acids of the matrix protein pp65 of human cytomegalovirus recognized by human lymphocytes
13. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection
14. Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens
15. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains
16. The DNA sequence of the human cytomegalovirus genome
17. Analysis of the protein coding content of the sequence of human cytomegalovirus strain AD169
18. Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: Relevance for epitope specific vaccination protocols
19. Infrequent occurrence of natural mutation in the pp65 (495-503) epitope sequence presented by the HLA-A*0201 allele among human cytomegalovirus isolates
20. Microscope-based multiparameter laser scanning cytometer yielding data comparable to flow cytometry data
21. Monitoring four herpes-viruses in unrelated cord blood transplantation
22. Quantitative analysis of cytomegalovirus load using a real-time PCR assay
23. Quantification of human cytomegaloviras DNA by real-time PCR
24. Status of activation of circulating vaccine-elicited CD8+ T cells
25. Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay
26. Status of cytomegalovirus prevention and treatment in 2000
27. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation
28. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers
29. Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts
30. Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma